China News Network, Xuzhou, March 4th (Reporter Zhu Zhigeng, correspondent Pei Zhengzheng) On March 4, Jiangsu's first patient with new coronary pneumonia treated with plasma, Mr. Jia Lao walked out of the isolation ward of the Xu Medical Affiliated Hospital and was cured with him And his son. On the day of discharge, the father and son bowed deeply to the medical staff who treated them as a token of gratitude.
Around February 3rd, 80-year-old Mr. Jia developed symptoms such as fever and cough. He received relevant basic treatment and nucleic acid testing at the local hospital. Combined with CT images, he was diagnosed with neo-pneumocoronary pneumonia on February 9 and transferred to Xu Medical Affiliated Hospital isolates the ward.
On behalf of the 80-year-old father and himself, Mr. Jia bowed deeply to the medical staff who treated them carefully. Photo by Wang Yikun
Mr. Jia has a history of over 20 years of hypertension, 6 years of cerebral infarction, and 5 years of fundus hemorrhage. He also had a cerebral aneurysm embolization 4 years ago. The admission examination also revealed that he had diabetes. When the elderly were admitted to the hospital with severe symptoms such as high fever, cough, sputum, and incontinence, the hospital listed it as the focus of attention, and organized multi-disciplinary expert consultations many times, but the condition was repeated and the lung inflammation was severe.
Considering that the patient is old, has many comorbidities, and is likely to develop in a critical direction or enter a protracted state, the hospital's treatment expert group decided to implement plasma treatment for patients with new coronary pneumonia recovery. With the knowledge and consent of the patient's family, with the support of the provincial and municipal health committees, on February 14, the hospital successfully infused the blood donated by the newly recovered patients with new coronary pneumonia. Thereafter, on February 26 and 27, the hospital underwent two plasma infusion boosters.
Mr. Jia recovered and was discharged from hospital with his son. Photo by Wang Yikun
After close observation during treatment, the treatment effect of the patient was obvious. Since February 29, the hospital has repeatedly performed multiple site viral and nucleic acid tests, and the results have been negative, and they have been discharged according to the latest national standards for the diagnosis and discharge of new coronary pneumonia.
"We had no hope for father's treatment. We didn't expect him to recover so well and stand up and walk out of the hospital." Talking about the treatment process, Mr. Jia Lao's son was moved to tears many times. He said that when his father entered the hospital for the first time, his condition was too serious. Since he was also a patient with neo-pneumonitis, it was very difficult for his father to take care of him. It's all doctors and nurses changing sheets for the elderly, cleaning the body, taking water, feeding. "Thank the party and the government, thank the Medical Affiliated Hospital of Xu, and thank you everyone. Because of you, my father and I have a second life, and we will never forget it in our lifetime." After leaving the isolation ward, the old man and son gave medical treatment. The personnel bowed deeply.
According to relevant experts from the Xu Yi Affiliated Hospital, according to the state-provided diagnosis and treatment plan, patients with New Coronary Pneumonia will have corresponding antibodies against New Coronavirus in their recovery period. The antibodies specific to New Coronavirus can effectively kill and clear the virus. This special-free plasma product is one of the currently effective treatments for neocoronavirus infection. It is expected to significantly reduce the mortality of critically ill patients. It has been implemented in many hospitals.
Before Mr. Jia was discharged from hospital, the medical staff examined it carefully. Photo by Wang Yikun
It is understood that, because it is the first case of neonatal coronary pneumonia patients in Jiangsu Province to perform plasma antibody treatment, in the afternoon of February 15th, the Propaganda Department of the Xuzhou Municipal Party Committee, the Health Committee of the Xuzhou City, and the Affiliated Hospital of the Xuzhou Medical University held a press conference for this purpose Workers shared the treatment plan with the public. In addition, Xu Medical Affiliated Hospital, the first unit in Jiangsu Province to carry out this diagnosis and treatment method, explored the ethical review, blood collection, separation, and transfusion processes, summarized the experience, and initially drafted the rehabilitation infusion plasma standard for recovery patients. Many regions and more hospitals have provided reference. (Finish)